T2 Biosystems, Inc.·4

Mar 28, 6:42 PM ET

Gibbs Michael Terrence 4

4 · T2 Biosystems, Inc. · Filed Mar 28, 2022

Insider Transaction Report

Form 4
Period: 2022-03-24
Gibbs Michael Terrence
General Counsel
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-2416,66616,667 total
    Common Stock (16,666 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-24+16,666165,441 total
  • Tax Payment

    Common Stock

    2022-03-24$0.44/sh8,790$3,876156,651 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]8,790 shares of common stock were automatically withheld at vesting to cover required tax withholding.
  • [F3]On March 24, 2020 the reporting person was granted 50,000 RSU's that vest in three equal annual installments commencing on March 24, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION